2025-03-23 • defenseworld.net
Wells Fargo & Company Lowers Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target to $1.502025-03-23 • defenseworld.net
Scotiabank Issues Pessimistic Forecast for Adaptimmune Therapeutics (NASDAQ:ADAP) Stock Price5 hours ago • prnewswire.co.uk
LG Energy Solution Secures Grid-scale ESS Supply Agreement in Europe with Poland's PGE6 hours ago • newsbreak.com
Newburyport Woman Arrested Following Early Morning Stabbing6 hours ago • newswire.ca
Minimizing litigation in Care-First system critical to delivering improved affordability and care to drivers6 hours ago • prnewswire.co.uk
In-Licensing Opportunity: How a Pharma Leader Leveraged Scientific Innovation for Clinical and Commercial Success | DelveInsight7 hours ago • newswire.ca
East Side Games Group Reports 2024 Financial Results7 hours ago • newswire.ca
David Sidoo Unveils Innovative Due Diligence Program for Advancing Sustainable Energy Solutions10 hours ago • arabianbusiness.com
Masdar Invested 8 2bn In 2024 As It Advances Renewable Energy Portfolio10 hours ago • newswire.ca
Investor Alert: Account Intrusion Scams10 hours ago • newswire.ca
PADLOCK EURO STORAGE FUND I COMPLETES ACQUISITION OF SWINDON PROPERTY11 hours ago • knnindia.co.in
Rajasthan Mining Stakeholders Demand Mineral Tax to Curb Raw Exports11 hours ago • bmmagazine.co.uk
Trump’s steel tariffs put £2.7bn of UK exports at risk as British manufacturers brace for impact12 hours ago • africanmanager.com
Tunisia: Slight decline in dam fill rate to 35.5%